Geriatric Patients in a Pre-rehabilitative Treatment, Mild Cognitive Impairment (MCI)
Conditions
Keywords
monitoring, cognitive appraisal
Brief summary
The study investigates the etiology of psychogical disorders from a neuropsychological perspective based on monitoring and cognitive appraisal.
Interventions
BEHAVIORALAX-CPT
administration of the AX-CPT
OTHERNo Interventions
Control group with no intervention treatment
Sponsors
St. Franziskus Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)
Eligibility
Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* geriatric patient of the St. Franziskus-Hospital, Germany.
Exclusion criteria
* severe dementia * delirium * psychotic disorders
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| AX-CPT (AX-Continuous Performance Test) | from beginning (day 2) of the hospitalization to the end (day 14) of the biweekly pre-rehabilitative treatment. | The AX-CPT assesses cognitive control through error rates and reaction times. Range: Error rate: 0-100%; Reaction time: measured in milliseconds Interpretation: Lower error rates and faster reaction times indicate better cognitive control performance. |
| CCFQ (Cognitive Control and Flexibility Questionnaire) | Day 1 (pretest) and Day 14 (posttest) | The CCFQ measures self-reported cognitive flexibility and control. Scale title: Cognitive Control and Flexibility Questionnaire Range: 1-7 per item Interpretation: Higher scores indicate greater cognitive flexibility and control. |
| BSI-18 (Brief Symptom Inventory - 18) | Day 1 (pretest) and Day 14 (posttest) | T he BSI-18 assesses psychological symptom severity in terms of depression, anxiety, and somatization.T Scale title: Brief Symptom Inventory - 18 Range: 0-4 per item Interpretation: Higher scores indicate greater symptom severity. |
| MHC-SF (Mental Health Continuum - Short Form) | Day 1 (pretest) and Day 14 (posttest) | Measures emotional, psychological, and social well-being. Range: 1-6 per item Interpretation: Higher scores indicate better mental health. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| General Self-Efficacy assessed via General Self-Efficacy Scale (SWE) | Day 1 (pretest) and Day 14 (posttest) | Evaluation of perceived self-efficacy across various life domains. Range: 1-4 per item Interpretation: Higher scores indicate greater self-efficacy. |
| Treatment Beliefs assessed via Palermo Questionnaire | Day 1 (pretest) and Day 14 (posttest) | Beliefs and expectations regarding treatment effectiveness. Range: 1-5 per item Interpretation: Higher scores indicate stronger and more positive treatment beliefs. |
Countries
Germany
Outcome results
None listed